|
|
®
The SMSI® system
is different in that it places the sensor (pictured
above, right, sitting on a finger) inside the body,
in continuous contact with the environment to be measured.
It is powered by an external reader (pictured above,
left) which receives continuous information and provides
it to the patient through a harmless, noninvasive, electromagnetic
transmission. SMSI is conducting studies expected to
demonstrate that its glucose monitoring system will
be superior to competing technologies.
The key distinguishing features
of SMSI's glucose monitor, which are being evaluated
in clinical studies, include:
- Minimally invasive. SMSI's
glucose sensor will be placed under the skin using
a needle delivery system called a trocar. There, it
will reside inside the body for six months to one
year, depending on the product lifetime as demonstrated
in clinical studies. Using telemetry, the sensor will
communicate its glucose measurements to an external
reader, without the need to draw blood.
- Continuous, effortless monitoring.
As long as the patient wears the external reader,
the SMSI system is intended to automatically record
a glucose level measurement every few minutes. Further,
it will be designed to alert the user to both impending
hyperglycemia and hypoglycemia.
- Accurate. Because no sampling
is involved, SMSI's glucose monitor is designed to
reduce the risk of user error substantially. Additionally,
the detection chemistry is highly sensitive and specific
for glucose. The SMSI glucose sensor does not need
to consume or produce chemicals while operating. The
sensor's interaction with glucose is fully reversible,
and the device operates in equilibrium with ambient
fluids.
- May enable improved care.
Clinical studies will evaluate whether use of the
device enables better diabetes management by giving
patients and healthcare providers easier to obtain
continuous glucose data. Patients and health care
providers can receive tailored summaries of the data
they need to make decisions.
- Excellent Specificity.
SMSI's sensor responds specifically to glucose, and
in testing so far, is not significantly affected by
other chemicals at concentrations typically present
in interstitial fluid.
SMSI's unique approach to glucose
monitoring is designed to avoid many of the problems
of traditional technologies, and is designed to provide
an unmatched combination of convenience, accuracy and
reliability.
Copyright © 2011 Sensors for Medicine and Science, Inc.®
All rights reserved. Date of last update: 11/2/11.
Refer to Terms and Conditions
for use of this Web site.
|
 |
